Stay updated with breaking news from Breaking Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING... | March 15, 2022
A senior Defence Research and Development Organization (DRDO) scientist Atul Dinkar Rane on Monday took over as the new Chief Executive Officer and Managing Dir
A senior Defence Research and Development Organization (DRDO) scientist Atul Dinkar Rane on Monday took over as the new Chief Executive Officer and Managing Director of the BrahMos Aerospace Limited which manufactures the BrahMos supersonic cruise missile, informed the DRDO officials.
Company Connecting the Dots for Final FDA Approval New York, New York--(Newsfile Corp. - June 3, 2021) - PCG Digital -- When Soligenix (NASDAQ: SNGX) updated its NDA rollout plan, the market quickly reacted.
HyBryte™ Expanded Efficacy and Safety Data Presented at the American Academy of Dermatology Meeting News provided by Share this article Share this article PRINCETON, N.J., April 26, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Ellen Kim, MD, Medical Director, Dermatology Clinic, Perelman Center for Advanced Medicine, Professor of Dermatology at the Hospital of the University of Pennsylva...